Clinical Trial Update: Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line pemetrexed plus cisplatin in patients with advanced non-squamous non-small cell lung cancer; the study was terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Carcinoma, Non Small Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2024-10-15